1. Completion of adjuvant chemotherapy following upfront surgical resection for pancreatic cancer may be too lofty a goal. (March 2019) Authors: Altman, A.M.; Wirth, K.; Marmor, S.; Chang, K.; Lou, E.; Hui, J.Y.C.; Tuttle, T.M.; Jensen, E.H.; Denbo, J.W. Journal: HPB Issue: Volume 21(2019)Supplement 1 Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy. (September 2018) Authors: Kizy, S.; Altman, A.; Hui, J.Y.C.; Tuttle, T.; Marmor, S.; Lou, E.; Greeno, E.; Chang, K.; Denbo, J.W.; Jensen, E. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Surgery may not improve survival for lymph node positive intrahepatic cholangiocarcinoma compared to chemotherapy alone. (March 2018) Authors: Kizy, S.; Altman, A.; Marmor, S.; Tuttle, T.M.; Hui, J.Y.C.; Denbo, J.W.; Jensen, E. Journal: HPB Issue: Volume 20(2018)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Surgery may not improve survival for node positive intrahepatic cholangiocarcinoma compared to chemotherapy alone. (September 2018) Authors: Kizy, S.; Altman, A.; Marmor, S.; Hui, J.Y.C.; Tuttle, T.; Denbo, J.W.; Jensen, E. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗